The factors affecting neurodevelopmental outcomes in HIE

Area of Science:

• Neonatal neurology
• Developmental pediatrics

Background:

• Hypoxic ischemic encephalopathy (HIE) is a serious condition in newborns with varied neurological outcomes.
• Therapeutic hypothermia is a standard treatment for HIE, but its long-term developmental impact requires further investigation.

Purpose of the Study:

• To assess developmental delays in neonates treated with therapeutic hypothermia for HIE.
• To identify risk factors associated with developmental outcomes in this population.

Main Methods:

• A retrospective cohort study was conducted.
• The Denver Developmental Screening Test II (DDST-II) was used to evaluate developmental progress.
• Data on Apgar scores, Sarnat stage, seizures, and interventions were analyzed.

Main Results:

• Thirteen out of 105 neonates exhibited abnormal development on the DDST-II.
• Seven patients were diagnosed with cerebral palsy, and others showed delays in gross motor, fine motor, or language skills.
• Lower Apgar scores and the presence of seizures were significantly associated with developmental delays and cerebral palsy.

Conclusions:

• Neonates treated for HIE with therapeutic hypothermia may experience developmental delays.
• Close monitoring is recommended for infants with low Apgar scores, seizures, high Sarnat stage, or delivery room intubation.